Clinical Investigations: Electrophysiology
Observations on the transition from intermittent to permanent atrial fibrillation,☆☆,

https://doi.org/10.1067/mhj.2000.107547Get rights and content

Abstract

Background Quantitative data on the frequency with which transition from intermittent to permanent atrial fibrillation occurs are lacking. We conducted this study to determine the proportion of patients with intermittent atrial fibrillation who progress to permanent atrial fibrillation and to investigate baseline clinical characteristics that might predict such a progression. Methods This retrospective cohort study included 231 patients who were seen with intermittent atrial fibrillation at a university hospital-based clinic from January 1978 through December 1997. Patients’ medical records and electrocardiograms were reviewed and data were collected for all clinic visits through May 1998. The proportion of patients who remained free of transition from intermittent to permanent atrial fibrillation was calculated by the Kaplan-Meier method. A Cox proportional hazards model was used to determine the effect of some baseline characteristics on this transition. Results The number of patients who remained free of transition from intermittent to permanent atrial fibrillation was 92% (95% confidence interval 88%-96%) at 1 year and 82% (95% confidence interval 75%-88%) at 4 years. Among 5 baseline characteristics (age, sex, structural heart disease, atrial fibrillation at presentation, and use of an antiarrhythmic medicine before presentation), the 2 significant predictors of progression from intermittent to permanent atrial fibrillation were age (P =.0003) and being in atrial fibrillation at presentation (P =.0006). The hazard ratio associated with 10 years of advancing age was 1.82 (95% confidence interval 1.31-2.51), and the hazard ratio associated with atrial fibrillation at presentation was 3.56 (95% confidence interval 1.73-7.34). Conclusions Approximately 18% of patients who had intermittent atrial fibrillation were permanently in atrial fibrillation after 4 years of follow-up. Age and being in atrial fibrillation at presentation were the only 2 important clinical variables identified in predicting such a progression. (Am Heart J 2000;140:142-5.)

Section snippets

Patients

The population of this study was a cohort of patients seen for atrial fibrillation in a hospital-based clinic by the same cardiologist from January 1978 through December 1997. To be considered for inclusion in the study, a patient had to have at least one episode of atrial fibrillation documented by a 12-lead electrocardiogram or by a transtelephonic rhythm strip. The electrocardiographic criteria for atrial fibrillation were a grossly irregular rhythm and the absence of discernible P waves.

Results

Three hundred thirty-one patients seen between January 1978 and December 1997 had documented atrial fibrillation. Some of the patients were excluded; 59 patients had permanent atrial fibrillation at presentation, 19 had Wolff-Parkinson-White syndrome, 2 had a history of His bundle ablation, 13 had pure atrial flutter, 6 had atrial fibrillation attributable to reversible causes, and 1 had concomitant ventricular arrhythmias requiring antiarrhythmic therapy. The remaining 231 patients were

Discussion

This study provides a quantitative estimate of the proportion of unselected patients with intermittent atrial fibrillation who progressed to permanent atrial fibrillation. This report shows that age and being in atrial fibrillation at presentation are strong predictors of such a progression. Despite the increasing incidence and high morbidity rates of atrial fibrillation, there are few studies that have addressed this aspect of atrial fibrillation in a quantitative fashion.

One previous natural

References (10)

  • WB Kannel et al.

    Coronary heart disease and atrial fibrillation: The Framingham study

    Am Heart J

    (1983)
  • PA Wolf et al.

    Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham study

    Arch Intern Med

    (1987)
  • PA Wolf et al.

    Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: The Framingham study

    Neurology

    (1978)
  • PA Wolf et al.

    Atrial fibrillation as an independent risk factor for stroke: The Framingham study

    Stroke

    (1991)
  • MM Gallagher et al.

    Classification of atrial fibrillation

    PACE

    (1998)
There are more references available in the full text version of this article.

Cited by (66)

  • Prediction of paroxysmal atrial fibrillation using new heart rate variability features

    2021, Computers in Biology and Medicine
    Citation Excerpt :

    AF patients often start with episodes of PAF before their condition escalates to a chronic stage. Furthermore, about 18% of PAF evolves to permanent AF (persistent or chronic) over 4 years [6]. AF can be treated by medication or electrical shock issued by the implantable defibrillator device (ICD) [7].

  • Prediction of paroxysmal Atrial Fibrillation: A machine learning based approach using combined feature vector and mixture of expert classification on HRV signal

    2018, Computer Methods and Programs in Biomedicine
    Citation Excerpt :

    Nevertheless, it is often associated with a high risk of cardiovascular morbidity and mortality [9]. The aim of therapy is to prevent stroke and regain sinus rhythm [10], however, prevention and treatment of AF is still far from satisfactory. Clinically, AF presents itself in different forms, commonly starting as paroxysmal, and becoming more persistent with time.

  • Paroxysmal atrial fibrillation prediction method with shorter HRV sequences

    2016, Computer Methods and Programs in Biomedicine
View all citing articles on Scopus

Dr Pritchett’s research in supraventricular arrhythmias has been supported by grant M01-RR00030 from the National Center for Research Resources, National Institutes of Health, Bethesda, Maryland.

☆☆

Guest Editor for this manuscript was Gust H. Bardy, MD, University of Washington, Seattle.

Reprint requests: Sana Al-Khatib, MD, Duke University Medical Center, Box 31071, Durham, NC 27710. E-mail: [email protected]

View full text